Evidence map›Paper›PMID 42032337›Full record

ArticleJournal of computer-aided molecular design2026

A systematic study of parameter sharing strategies in multi-task learning for drug synergy and sensitivity prediction.

C A Hafsath, A S Jereesh

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

C A HafsathDepartment of Computer Science, Cochin University of Science and Technology, Cochin, Kerala, 682022, India. hafsath@cusat.ac.in.
A S JereeshDepartment of Computer Science, Cochin University of Science and Technology, Cochin, Kerala, 682022, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multi-task learning (MTL) is a useful approach for modeling related prediction tasks by sharing representations while allowing each task to keep its unique features. In computational drug discovery, drug synergy and drug sensitivity predictions are closely linked, but it is still unclear where and how to share model parameters between these tasks. In this study, we introduce a multi-task learning framework that predicts both drug synergy and drug sensitivity, with a main goal of improving synergy prediction by using sensitivity prediction as a supporting task. Our model uses molecular descriptors and drug induced gene expression signatures to describe pharmaceuticals, while untreated cancer cell lines are described by their baseline gene expression profiles. We use a mutual attention mechanism to capture complex interactions between drugs and cells. With this shared feature extraction base, we systematically test different parameter sharing strategies, looking at both hard and soft sharing at various network depths. Our experiments show that the success of parameter sharing depends on both the sharing strategy and the network layer where sharing happens. Hard parameter sharing works best at deeper layers, while soft parameter sharing allows for more stable and flexible knowledge transfer between tasks. Among the soft sharing methods we tested, dense sharing based on Neural Discriminative Dimensionality Reduction (NDDR) consistently outperforms cross stitch and sluice networks, especially when used in early network layers. Extending dense sharing to multiple layers further improves shared representations and leads to better performance. An updated NDDR version with nonlinear bottleneck transformations and residual connections achieves the highest overall performance. In summary, this work gives clear insight about where and how information should be shared in multi-task learning for drug synergy and sensitivity prediction. Our results show that both the sharing level and the way sharing is done strongly affect performance. Multi-level and depth-aware sharing strategies lead to better predictions. These findings give practical guidance for building effective multi-task models in computational drug discovery.

Indexed as

Antineoplastic AgentsDrug DiscoveryDrug SynergismMachine LearningAlgorithmsCell Line, TumorHumansAntineoplastic AgentsCombination therapyCross stitchNDDRSluiceSynergy score

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.